Glatiramer: a second look. With longer follow-up: still no proven benefit in multiple sclerosis
- PMID: 20025092
Glatiramer: a second look. With longer follow-up: still no proven benefit in multiple sclerosis
Similar articles
-
Glatiramer: new preparation. No place in multiple sclerosis.Prescrire Int. 2004 Feb;13(69):10-2. Prescrire Int. 2004. PMID: 15055208
-
Glatiramer acetate for relapsing multiple sclerosis.Med Lett Drugs Ther. 1997 Jul 4;39(1004):61-2. Med Lett Drugs Ther. 1997. PMID: 9217693 Clinical Trial. No abstract available.
-
[Immunomodulatory therapy in multiple sclerosis].Ideggyogy Sz. 2004 Nov 20;57(11-12):401-16. Ideggyogy Sz. 2004. PMID: 15662768 Review. Hungarian.
-
[Long-term effects of glatiramer acetate in multiple sclerosis].Rev Neurol (Paris). 2008 Nov;164(11):917-26. doi: 10.1016/j.neurol.2008.02.045. Epub 2008 May 16. Rev Neurol (Paris). 2008. PMID: 18790510 French.
-
Copolymer 1 from the laboratory to FDA.Isr J Med Sci. 1997 Apr;33(4):280-4. Isr J Med Sci. 1997. PMID: 9347880 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical